Cancer Treatment in South Korea: What the Data Actually Shows
South Korea has major academic cancer centers with documented clinical volumes, survival data, and specialized programs including proton therapy, robotic surgery, and CAR-T. But infrastructure alone does not answer the question that matters: does a specific Korean center match this patient's clinical need?
Quick Answer
South Korea is worth evaluating when a specific clinical need matches the expertise of a Korean cancer center. The decision order is: Cancer → Current treatment question → Required capability → Destination → Hospital → Treatment. Not the reverse.
What the Data Shows — With Sources
Gastric Cancer: Samsung Medical Center
Samsung Medical Center reported a 5-year relative survival rate for gastric cancer patients of 89.5%, compared with the Korean national average of 78.6% and the US average of 37.9% [citation:3][citation:10]. The 90-day post-surgical mortality rate was 0.42%, compared to the average of 0.98% across Korea's top-tier general hospitals [citation:17].
In 2025, 256 of 1,174 gastric cancer surgeries (22%) at Samsung were performed robotically, and the center has surpassed 1,500 cumulative robotic gastric surgeries [citation:17]. Samsung is the only Korean institution with a dedicated da Vinci 5 system assigned exclusively to gastrointestinal surgery [citation:3].
Lung Cancer: Seoul National University Hospital
SNUH performs approximately 700–800 lung cancer surgeries annually, with more than 80% performed via minimally invasive approaches (VATS or robotic) [citation:4]. The 30-day post-surgical mortality rate is below 0.3%, and 5-year survival exceeds 80% for stage I patients [citation:4].
CAR-T: Limcarto (Curocell)
Korea's first domestically developed CAR-T therapy, Limcarto (anbalcabtagene autoleucel), received MFDS approval in April 2026 for relapsed/refractory DLBCL and PMBCL after two or more prior lines of therapy [citation:27]. Phase 2 data showed an objective response rate of 75.3% and a complete remission rate of 67.1% [citation:35]. Supply is being established at 12 major hospitals initially, expanding to 30 by end-2026, including Samsung Medical Center and Asan Medical Center [citation:27].
Proton Therapy: National Cancer Center + Samsung
Korea currently operates proton therapy at the National Cancer Center (NCC, since 2007) and Samsung Medical Center, with a third center under development [citation:39]. NCC treats approximately 300–400 patients annually and has particular expertise in pediatric cancers, liver cancer, and lung cancer [citation:39].
Cost Data — With Caveats
CancerCareE does not publish a single "Korea cancer treatment cost" number. But the following source-specific figures provide a starting point for comparison.
| Service | Korea (Estimated Range) | Source & Date | Caveat |
|---|---|---|---|
| Proton therapy (full course) | $15,000 – $30,000 | In Korea Now, 2026-04 [citation:39] | Secondary source — verify with center |
| Gastric cancer surgery (Seoul, average) | ~$19,494 (range $12,173–$29,000) | Bookimed, April 2026 [citation:24] | Aggregator — treat as directional |
| Gastric cancer surgery (hospital range) | ₩4.7M – ₩9.96M (≈$3,400–$7,200) | HIRA via MedicalTimes, 2026-07 [citation:25] | Official insurance data — but Korean resident pricing, not international patient pricing |
Important: The HIRA data (₩4.7M–₩9.96M) reflects Korean National Health Insurance reimbursement rates — not what international patients pay. International patient pricing is typically higher. Always request a written, treatment-specific estimate from the hospital.
Telemedicine for Foreign Patients — New Legal Framework
In May 2026, Korea amended the Medical Overseas Expansion Act to formally permit telemedicine services for foreign patients, including first-time consultations [citation:29]. The law takes effect one year after promulgation (May 2027).
Covered services include: continuous monitoring, counseling and education, diagnosis, and prescription [citation:21]. This means foreign patients may be able to receive pre-arrival consultations and post-return follow-up care remotely from Korean hospital-level institutions [citation:22].
Asan Medical Center already operates an AI-powered integrated platform for international patients to register, share medical records, book pre-consultations, and receive remote treatment [citation:22].
Medical Visa Options
| Visa Type | Duration | Purpose | Key Requirement |
|---|---|---|---|
| C-3-3 (Medical Tourism) | Up to 90 days | Short-term treatment or recuperation | Appointment confirmation from registered hospital + proof of funds [citation:30] |
| G-1-10 (Treatment) | Up to 1 year | Extended treatment or recovery | Same documentation; for longer stays [citation:23] |
Immediate family members may apply for the same visa category with relationship documentation [citation:23].
Major Centers — Documented Capabilities
Samsung Medical Center
Documented: 1,500+ robotic gastric surgeries, dedicated da Vinci 5 for GI surgery, gastric cancer 5-year survival 89.5%, 90-day post-op mortality 0.42% [citation:3][citation:17]. One of the initial 12 hospitals for Limcarto CAR-T supply [citation:27].
Seoul National University Hospital (SNUH)
Documented: 700–800 lung cancer surgeries/year, >80% minimally invasive, 30-day post-op mortality <0.3%, stage I 5-year survival >80% [citation:4]. Has an International Healthcare Center.
Asan Medical Center
Documented: Dedicated CAR-T Cell Therapy Center; one of the initial 12 hospitals for Limcarto supply [citation:27]; AI-powered international patient platform with telemedicine since 2021 [citation:22].
National Cancer Center (NCC)
Documented: Korea's first proton therapy center (since 2007); treats ~300–400 patients/year; government-run, pricing tends to be at lower end of Korean range [citation:39].
Note: CancerCareE does not rank hospitals. The relevant question is whether a specific center has the specialist and pathway required for this case.
Explore Specific Topics
Cancer Treatment Costs in Korea
Treatment-specific estimates with sources and caveats
Proton Therapy in Korea
Centers, indications, costs, and evidence
CAR-T in Korea
Limcarto, Kymriah, Yescarta — products, indications, centers
Stomach Cancer in Korea
Samsung data, robotic surgery, survival outcomes
Korea vs China
Established standard vs experimental access
Telemedicine with Korean Centers
New legal framework for remote consultations
Frequently Asked Questions
Is South Korea good for cancer treatment?
South Korea has major academic centers with documented clinical volumes and outcomes — for example, Samsung Medical Center's 89.5% 5-year relative survival for gastric cancer [citation:3]. Whether it is appropriate for an individual patient depends on the specific cancer, treatment question, and whether a Korean center has the relevant specialist and pathway.
How much does cancer treatment cost in South Korea?
There is no single number. Source-specific figures: proton therapy full course $15,000–$30,000 [citation:39]; gastric cancer surgery in Seoul ~$19,494 average (Bookimed aggregator) [citation:24]; HIRA official data shows ₩4.7M–₩9.96M for gastric surgery but this is Korean resident pricing, not international patient pricing [citation:25]. Always request a written, treatment-specific estimate.
Does South Korea have CAR-T therapy?
Yes. Korea's first domestically developed CAR-T, Limcarto (Curocell), was approved in April 2026 for relapsed/refractory DLBCL and PMBCL after ≥2 prior lines [citation:27]. It is being supplied to 12 major hospitals initially, expanding to 30 by end-2026 [citation:27]. Asan Medical Center also operates a dedicated CAR-T Center.
Can international patients get telemedicine consultations from Korean hospitals?
Korea amended its Medical Overseas Expansion Act in May 2026 to permit telemedicine for foreign patients, including first-time consultations [citation:29]. The law takes effect one year after promulgation (May 2027). Asan Medical Center already offers telemedicine to foreign patients [citation:22].
What visa do I need for cancer treatment in Korea?
Most patients need a C-3-3 medical tourism visa (up to 90 days) or G-1-10 treatment visa (up to 1 year). Required documents include an appointment confirmation from a registered Korean hospital and proof of financial ability to cover treatment and stay [citation:23][citation:30].
Define Your Question First
You do not need to start by choosing a hospital. Start by defining the diagnosis, what has been tried, what decision needs to be made now, and what capability you are looking for.